Recognition and Publications

Center for the Study of Primary Biliary Cirrhosis

  1. Schaffner F, Bach N. Gastrointestinal syndromes in primary biliary cirrhosis. Semin Liver Dis 1989; 8263-271.
  2. Bach N, Schaffner F. Familial primary biliary cirrhosis. J Hepatology 1994; 20: 698-701.
  3. Bach N, Schaffner F. The histological effects of low dose methotrexate therapy for primary biliary cirrhosis. Arch Pathol Lab Med 1998; 122: 342-345.
  4. Odin JA, Huebert RC, Casciola-Rosen L, LaRusso NF, Rosen A. Bcl-2-dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis. J Clin Invest 2001; 108: 223-232.
  5. Sasaki M, Allina J, Odin JA, Thung SN, Coppel R, Nakanuma Y, Gershwin ME. Autoimmune cholangitis in the SJL/J mouse is antigen non-specific. Dev Immunol 2002; 9: 103-111.
  6. Bach N, Bodian C, Bodenheimer H, Croen E, Berk PD, Thung SN, Lindor K, Therneau T, Schaffner F. Methotrexate therapy for primary biliary cirrhosis. American J Gastroenterol 2003; 98: 1-7.
  7. Stanca CM, Fiel MI, Allina J, Caracta CF, Odin JA. Liver failure in an antimitochondrial antibody-positive patient with sarcoidosis: primary biliary cirrhosis or hepatic sarcoidosis? Semin Liver Dis 2005; 25: 364-370.
  8. Selmi C, Mayo MJ, Bach N, Invernizzi P, Gish RG, Gordon SC, Wright HI, Zweiban B, Podda M, Gershwin ME. Primary biliary cirrhosis in monozygotic and dizygotic twins: Genetics, epigenetics and environment. Gastroenterol 2004; 127:  485-492.
  9. Stanca CM, Bach N, Krause C, Tandon N, Freni MA, Gutierrez JA, Bodian C, Schiano TD, Branch AD, Odin JA. Evaluation of fatigue in U.S. patients with primary biliary cirrhosis. Am J Gastroenterol 2005; 100: 1104-1109.
  10. Ala A, Stanca CM, Bu-Ghanim M, Ahmado I, Branch AD, Schiano TD, Odin JA, Bach N. Increased prevalence of primary biliary cirrhosis near superfund toxic waste sites. Hepatology 2006; 43: 525-531.

Primary Sclerosing Cholangitis Studies

  1. Bu-Ghanim M, Suriawinata A, Killackey M, Schwartz ME, Jaffe D, Fiel MI. Invasive colloid carcinoma arising from intraductal papillary neoplasm in a 50-year-old woman with primary sclerosing cholangitis. Semin Liver Dis. 2004 May; 24(2): 209-13.
  2. Allina J, Odin JA. Aetiology and pathogenesis of primary sclerosing cholangitis. In Disease Progression and Disease Prevention in Hepatology and Gastroenterology. PR Galle, G Gerken, WE Schmidt, B Wiedenmann, eds. Springer, Inc., Norwell, MA. 14-22. 2006.
  3. Stanca CM,, Odin JA. Clustering of primary sclerosing cholangitis near toxic waste sites. In press.

Autoimmune Hepatitis Studies

  1. Thung SN, Bach N, Fasy TM, Jordan D, Schaffner F. Hepatocellular carcinoma associated with autoimmune chronic active hepatitis. Mt Sinai J Med 1990; 57: 165-168.
  2. Bach N, Thung SN, Schaffner F. Comparative analysis of the histology of hepatitis C and autoimmune chronic active hepatitis. Hepatology 1992; 15: 572-577.
  3. el Younis CM, Min AD, Fiel MI, Klion FM, Thung SN, Faire B, Miller CM, Bodenheimer HC Jr.. Autoimmune hepatitis in a patient with sickle cell disease. Am J Gastroenterol. 1996 May; 91(5): 1016-8.